Project Grant R01NS138422

Award Date 9/18/24
Completion Date 6/30/29
Dollars Obligated $628K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $638,718 to support research on selective, epineural stimulation of peripheral nerves using interferential electrical fields. The primary objective is to develop and validate a multi-contact cuff electrode design and optimization methodology to selectively activate specific...
This $596,582 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of Neuronoff Inc.'s Injectrode technology. The Injectrode is an injectable, flexible electrode designed for less invasive neural modulation therapies. The grant will fund the optimization and validation of the Injectrode for baroreceptor activation therapy to treat hypertension and heart failure. Neuronoff Inc. also...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is funding the development of a wireless, battery-free bioelectronic implant system for autonomous closed-loop neuromodulation management of detrusor sphincter dyssynergia (DSD) in individuals with spinal cord injury. The University of Houston System, the awardee, will fabricate...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $970,052 to Backstop Neural, Inc. to demonstrate the feasibility of a novel epidural stimulation lead for treating chronic arm and neck pain. The key objectives are to: 1) Design and fabricate a 16-channel, 0.2 mm thick softening paddle lead that can conform to the spinal cord; 2) Demonstrate the mechanical and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,976 to Ecate LLC aims to develop a novel intraspinal stimulator system to restore sensation and volitional motor control in spinal cord injury patients. The project will fabricate nanopatterned stimulating electrodes coupled with custom CMOS chips to deliver spatially selective electrical stimulation to the spinal cord. This closed-loop neural interface system is intended...
This $566,015 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), supports the University of Utah's development of a configurable and thermo-responsive intracortical electrode array platform using 3D printing and gallium-based liquid metal electrode materials. The goal is to create a next-generation implantable neural...
The University of Nebraska Medical Center (UNMC) was awarded a $437,331 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will support the development of a novel "optoelectronically active nerve adhesive" to accelerate peripheral nerve repair and regeneration. Specifically, the project aims to incorporate innovative...
This National Science Foundation (NSF) Engineering Program (CFDA 47.041) Project Grant award of $100,001 to the University of Wisconsin System, through its University of Wisconsin - Madison division, will advance the development of new magnetoelectric nanostructures for minimally invasive brain monitoring and stimulation. The project aims to create specialized cobalt ferrite (CFO) and barium titanate (BTO) nanoparticles that can be safely injected into the brain to detect neural activity using...
This $260,609 Project Grant from the National Science Foundation Division of Electrical, Communications and Cyber Systems will support the development of multi-channel, sub-microliter implants for selective neuromodulation at Boise State University from September 1, 2023 through August 31, 2028. The grant is jointly funded through NSF's Engineering Directorate and Established Program to Stimulate Competitive Research, both of which aim to advance innovation in engineering research. Under this...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, awarded the University of Oregon a $301,172 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The purpose of this 3-year project is to develop scalable fabrication methods for high-density amorphous silicon carbide microelectrode arrays to enable chronic neural interfacing for recording neural activity in studies...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support the development and validation of a novel minimally invasive electrode technology to better target the posterior tibial nerve for treating overactive bladder (OAB).

The $628,012 award to the University of Wisconsin System will fund the design, fabrication, and testing of an injectable electrode, called the "Injectrode", to improve nerve engagement and reduce complications compared to existing posterior tibial nerve stimulation (PTNS) devices. The project involves collaborations with Neuronoff Inc. to supply the Injectrode devices, Case Western Reserve University to model the nerve anatomy and conduct animal studies, and Massachusetts General Hospital to develop optical probes for integration with the electrodes. The award has a period of performance from September 2024 through June 2029.

Generated 7/1/25, 3:43 AM